Background. The aim of this study was to survey the effect of deposited iron on the cell kinetics of hepatitis C virus (HCV)-positive hepatocellular carcinoma (HCC) in Myanmar (Burmese) patients. Methods. Formalin-fi xed and paraffi n-embedded liver tissues from 34 Myanmar patients with HCC were used. To detect iron deposition, Prussian blue staining was performed. Cell proliferation and apoptosis were assessed by Ki-67 staining and by the terminal deoxynucleotidyl trans ferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL) assay, respectively. HCV RNA was detected by in situ hybridization, and HCV protein, Fas and Fas ligand (FasL) were localized by immunohistochemistry. To identify the subtype of lymphocytes, CD8 was used as a surface marker. Results. Iron deposition was found in 43% of the HCC cases, and was heavier in moderately differentiated HCC than in welldifferentiated HCC. The Ki-67 labeling index (LI) in cancer cells was higher in Prussian blue-positive-HCC than in -negative HCC (3.8 ± 2.2 vs 1.5 ± 1.7, mean ± SD; P = 0.0067), whereas there was no signifi cant difference between these groups in TUNEL LI. HCV protein was localized in cancer cells, and was found in 89% of the patients. In addition, Fas was expressed in HCC cells, and FasL was localized in HCC cells as well as in infi ltrating CD8+ T lymphocytes. The frequency of apoptosis of HCC cells was correlated signifi cantly with the population density of infi ltrating CD8+ T lymphocytes. Conclusions. Our results indicated that, in Myanmar patients with HCC, iron deposition might accelerate hepatocarcinogenesis, by promoting cancer cell proliferation, without affecting the Fas/FasL apoptotic system.
Introduction
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. However, the incidence of HCC varies considerably with the geographic area because of differences in the major causative factors. Among these, it is widely believed that hepatitis C virus (HCV) is responsible for the great majority of cases of HCC. 1 In particular, HCV infection is endemic in Japan, Italy, and Southeast Asia, with serum antibodies against HCV having been found in as many as 76% of patients with HCC in Japan, 75% in Italy, and 65% in Indonesia. 1, 2 The incidence of HCC in cirrhotic carriers of HCV is also estimated to be about 5% per year, ten times higher than that in hepatitis B virus (HBV) carriers. 3 In Myanmar (formerly Burma), the juvenile development and poor prognosis of HCC in the younger generation is one of the most urgent concerns in the medical fi eld. 4 Okada et al. 5 reported a high prevalence of hepatitis C in Myanmar patients with liver diseases; 21.4% of patients with HCC had the antibody against HCV. Furthermore, Nakai et al. 6 reported that hepatitis viruses were widespread in Myanmar and were associated with the high incidence of acute and chronic liver diseases; 24% of HCC patients in Myanmar were found to be infected with HCV, while more than half of the HCC patients were HBV-positive.
The liver is a central organ in iron metabolism, including iron absorption and storage. Disruption of cellular iron homeostasis can lead to iron defi ciency or iron overload. In iron-overload diseases, the generation of reactive oxygen species by excess hepatic iron may cause liver-cell injury, resulting in fi brosis and cirrhosis in the liver. [7] [8] [9] Although various factors such as hepatitis viruses and carcinogens have been implicated as a major cause of the induction of HCC, it has been recently highlighted that excess uptake of iron is possibly involved in the progression of carcinogenesis. [10] [11] [12] In fact, experimental studies have supported the hypothesis that iron may facilitate the development of HCC in cirrhotic or noncirrhotic patients. 13, 14 Accumulation of iron is also frequent in the livers of patients with HCV infection. 15, 16 Moreover, recent reports have demonstrated that chronically HCV infected-patients treated with long-term iron reduction therapy have a signifi cant improvement of liver function and a marked reduction in progression to HCC. 17, 18 However, the effects of iron accumulation in the liver, which is often experienced in Myanmar, on the pathogenesis of carcinoma remain to be clarifi ed.
It is known that the induction of hepatocyte apoptosis upon HCV infection is critical for liver damage and the progression of HCC. 19, 20 Apoptosis is an active mode of cell death, 21 and as a triggering molecular mechanism the involvement of the Fas and Fas ligand (FasL) system has been often examined, especially in viral hepatitis. 22 In chronic HCV infection, it has been reported that the expression of Fas in hepatocytes is upregulated and FasL is expressed in infi ltrating cells. 23 Also, Fukuzawa et al. 24 have reported that Fas/FasL expression in some HCC cells, as well as in hepatocytes, is enhanced with infi ltrating CD8+ T lymphocytes, and that these infi ltrating infl ammatory cells play an important role in the induction of apoptosis in HCC. However, it is still not clear whether the expression of HCV protein directly affects the apoptosis induced by the Fas/FasL system in HCC. [25] [26] [27] [28] To our knowledge, there are no reports on the correlation between iron deposition and the apoptosis of HCC cells.
Therefore, in the present study, using surgically excised HCC specimens from Myanmar patients, we fi rst examined iron deposition by Prussian blue staining, and correlated it with the pathological classifi cation of HCC. And then, after confi rming the presence of HCV by immunohistochemistry, the cell kinetics of proliferation and cell death were assessed by Ki-67 staining and terminal deoxynucleotidyl transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL), respectively. In addition, the expression of Fas and FasL in HCC cells and infi ltrating CD8+ lymphocytes, as well as in hepatocytes, was assessed immunohistochemically.
Patients, materials, and methods

Patients
Thirty-four specimens were diagnosed as HCC in the Pathology Research Division, Department of Medical Research (Lower Myanmar), Myanmar. The age of the HCC patients at diagnosis ranged from 29 to 69 years (49 ± 12; mean ± SD). Twenty-seven patients were males and 7 were females. The clinicohistopathological features of the patients are listed in Table 1 . The liver tissue blocks were fi xed in 10% buffered formalin and embedded in paraffi n. The same paraffi n-embedded tissue blocks were used for hematoxylin and eosin (H&E) staining, Prussian blue staining, immunohistochemical staining, and the TUNEL assay. Five-µm-thick sections were mounted on 3-aminopropyltriethoxysilane (Sigma Chemical, St Louis, MO, USA)-coated glass slides. All specimens were collected in accordance with the guidelines of the World Medical Association Helsinki Declaration and with the approval of the Nagasaki University Institutional Review Board. This study was a JapanMyanmar collaborative research, conducted by collaboration between Nagasaki University and the Ministry of Health, Myanmar.
Antibodies
Anti-Ki-67 (1: 200; MIB 1) was purchased from Immunotech (Marseille, France). Anti-HCV core (1: 100; clone 1E5) was purchased from Chemicon International (Temecula, CA, USA). Anti-HCV NS3 (1: 200) was purchased from Biogenex (San Ramon, CA, USA). Anti-Fas (FasC; 1: 200) serum was prepared by immunization of rabbits against synthetic oligopeptides corresponding to the intracellular domain of amino acids 300-314 of human Fas protein. 29, 30 Anti-FasL (1: 200; P5) was generated with a synthetic peptide corresponding to the intracellular domain (P5; amino acids 41-55) of rat FasL. 31, 32 Anti-CD8 (1: 100) was purchased from MBL (Nagoya, Japan). Horseradish peroxidase (HRP)-labeled goat anti-mouse IgG (1: 100) and HRP-labeled goat anti-rabbit IgG (1: 200) were purchased from MBL. HRP-labeled anti-biotin (1: 100) was purchased from Vector Laboratories (Burlingame, CA, USA). Normal rabbit IgG, normal goat IgG, and normal mouse IgG were purchased from Sigma, and normal rabbit serum was purchased from Dako (Glostrup, Denmark).
Prussian blue staining
To detect the deposition of iron, Prussian blue staining was performed as described previously. 33 Briefl y, the sections were deparaffi nized and rehydrated by the standard procedure, and then rinsed with Milli-Q (Millipore, Japan) water. The sections were placed into working solution (potassium ferrocyanide 2 g in Milli-Q water 100 ml + concentrated hydrochloric acid 1 ml in Milli-Q water 100 ml) for 20 min. Then, the sections were rinsed with Milli-Q water and stained with neutral red solution for 5 min, dehydrated, then mounted using a standard procedure.
Hepatic iron distribution was assessed according to the histological hepatic iron index (HHII) described by Deugnier et al. 34 and Saito et al. 35 The HHII was assessed according to the size and cellular and lobular locations of iron deposits in Rappaport's acinus, leading to three different scores: hepatocytic, sinusoidal, and portal iron scores (HIS, SIS, and PIS, respectively). The HIS included iron deposition in cancer cells as well as in hepatocytes. The sum of these scores was defi ned as the total iron score (TIS; range, 0 to 60).
Immunohistochemistry
Immunohistochemical staining for HCV core and HCV NS3 protein, Ki-67, Fas, FasL, and CD8 was performed as described previously. [29] [30] [31] [32] Briefl y, the sections were deparaffi nized and rehydrated by the standard procedure. For HCV NS3 and CD8 staining, the sections were microwaved at 95°C for 10 min and autoclaved at 110°C for 10 min, respectively, in 0.01 M citrate buffer (pH 6.0). After a washing in 0.01 M phosphate-buffered saline (PBS; pH 7.2), endogenous peroxidase was blocked by 0.3% H 2 O 2 in methanol for 15 min, and the sections were preincubated with PBS containing 500 µg/ ml normal goat IgG and 1% bovine serum albumin (BSA) for 60 min. The sections were reacted overnight with monoclonal mouse anti-HCV core IgG and/or monoclonal mouse anti-HCV NS3 and monoclonal mouse anti-human Ki-67 IgG.
For Fas and FasL immunohistochemistry, the sections were reacted with rabbit anti-Fas C antiserum and rabbit anti-FasL antiserum for 2 h. For CD8 staining, the sections were reacted with mouse monoclonal antihuman CD8 antibody for 2 h. After a washing in 0.075% Well, well differentiated; moderate, moderately differentiated; poor, poorly differentiated; ND, not determined; M, male patient; F, female patient; +, positive staining; −, negative staining; HCV core, hepatitis C virus core protein; HCV NS3, hepatitis C virus NS3 protein; HBsAg, history of positivity for hepatitis B surface antigen Brij 35 (Sigma) in PBS, the sections were reacted with HRP-goat anti-mouse IgG or HRP-goat anti-rabbit IgG for 1 h. After a washing in 0.075% Brij 35, the sites of HRP were visualized with 3,3′-diaminobenzidine-4 HCl (DAB; Dojin Chemical, Kumamoto, Japan) and H 2 O 2 (Wako Pure Chemical Industries, Osaka, Japan). As a negative control, serial sections were reacted with normal mouse IgG or normal rabbit serum instead of the specifi c antibodies. Unless otherwise specifi ed, all procedures were performed at room temperature.
In situ hybridization
The oligodeoxynucleotide (oligo-DNA) sequences of plus-and minus-strand HCV RNAs were synthesized (Bex, Tokyo, Japan) for in situ hybridization. The sequence of the region of prototype HCV (−36 to 8) was used as a sense HCV oligo-DNA. 36, 37 To these oligoDNAs were added two or three repeats of thyminethymine-adenine at the 5′ and 3′ ends, respectively, for the thymine-thymine (T-T) dimers, as described in detail previously. 38 The procedures for in situ hybridization were described previously in detail. [39] [40] [41] Briefl y, the sections were deparaffi nized and rehydrated according to the standard procedures. The sections were treated with 0.2 N hydrochloric acid for 20 min and digested with 100 µg/ml of proteinase K for 15 min at 37°C. After post-fi xation with 4% paranormal-dehyde in PBS for 5 min, the sections were immersed in 2 mg/ml glycine in PBS for 15 min twice and kept in 40% deionized formamide in 4 × standard saline citrate (SSC; 1 × SSC = 0.15 M sodium chloride and 0.015 M sodium citrate, pH 7.0) until used for hybridization. Hybridization was carried out at 37°C overnight with 4 µg/ml T-T labeled oligo-DNA probes dissolved in the hybridization medium. After repeated washings, the signals were detected by enzyme-immunohistochemistry. Visualization of HRP sites was performed with DAB, H 2 O 2 , CoCl 2 , and NiSO 4 (NH 4 ) 2 SO 4 according to the method of Adams. 42 To evaluate the level of hybridizable RNAs in tissue sections, duplicate serial sections were used for the 28S rRNA probe as a positive control in every case. 43 Unless otherwise specifi ed, all procedures were done at room temperature.
TUNEL staining
The TUNEL assay was carried out according to the method of Gavrieli et al., 44 with a slight modifi cation, as described previously. 45 Briefl y, the paraffi n-embedded sections were deparaffi nized with toluene and rehydrated in serially graded ethanol solutions. After a washing with PBS, the sections were treated with 5 µg/ ml proteinase K in PBS for 15 min at 37°C. The sections were then incubated with TdT buffer (25 mM Tris-HCl buffer, pH 6.6, containing 0.2 M potassium cacodylate and 0.25 mg/ml BSA; Roche Diagnostics, Mannheim, Germany) alone for 30 min. After incubation, the slides were reacted with 100 U/ml TdT (Roche Diagnostics) in TdT buffer supplemented with 1.5 mM CoCl 2 , 0.5 µM biotin-16-dUTP, 20 µM dATP, and 0.1 mM dithiothreitol for 90 min at 37°C. The reaction was terminated by washing with 50 mM Tris-HCl buffer (pH 7.4), and endogenous peroxidase activity was inhibited by immersing the slides in 0.3% H 2 O 2 in methanol for 15 min, followed by washing with PBS. After incubation with 500 µg/ml normal goat IgG in 5% BSA in PBS for 60 min, the sections were incubated overnight with HRP-goat anti-biotin antibody (1: 100 dilution; Vector Laboratories, Burlingame, CA, USA) diluted with 5% BSA in PBS. After a washing with 0.075% Brij 35 in PBS, the HRP sites were visualized with DAB, H 2 O 2 , CoCl 2 , and NiSO 4 (NH 4 ) 2 SO 4 according to the method of Adams. 42 As a negative control, some sections were reacted in TdT-free media. Finally, the slides were dehydrated and mounted without counterstaining.
Identifi cation of cell type of FasL-positive cells in Myanmar HCC tissues
To identify the type of FasL-positive cells, we performed double-staining for FasL and CD8 by immunohistochemistry in the sections of Myanmar HCC tissues, as described previously. 46 The sections were reacted with anti-CD8 antibody and anti-FasL serum. After deparaffi nization, the slides were stained with anti-CD8 antibody according to the protocol described above, and HRP sites were visualized with DAB and H 2 O 2 . Then the sections were immersed three times in 0.1 M glycineHCl buffer (pH 2.2) for 30 min. After a washing with Milli-Q water once and immersion in PBS three times, the sections were stained with anti-FasL by the same indirect immunohistochemistry as that described above. The sections were visualized with 4-chloro-1-naphthol (Tokyo Kasei Kogyo, Tokyo, Japan) and H 2 O 2 solution.
Quantitative analysis
The results of immunohistochemistry for HCV core protein, HCV NS3 protein, Ki-67, Fas, and 
Statistical analysis
All data values were expressed as means ± SD. Differences between groups were examined for statistical signifi cance using the unpaired Student's t-test. The correlation between the HHII (total iron score) and iron deposition (Prussian blue-positive area [%] ) and the correlation between cell proliferation (Ki-67 LI) and iron deposition (Prussian blue positive area [%]) were assessed by linear regression analysis (analysis of variance; ANOVA). A P value of less than 0.05 denoted the presence of a statistically signifi cant difference. All analyses were performed with a statistical software package (StatView, version 5.0; Abacus Concepts, Berkeley, CA, USA).
Results
Localization of HCV proteins and their RNAs in Myanmar HCC
To detect the localization of HCV protein in Myanmar HCC tissues, we performed immunohistochemistry. HCV core protein was localized in the cytoplasm and nuclei of cancer cells (Fig. 1a) . On the other hand, HCV NS3 protein was localized in the nuclei of cancer cells (Fig. 1b) . In our hands, the use of anti-HCV NS3 protein provided us with more sensitive results than anti-HCV core protein, though the distribution of HCVpositive cells was essentially the same for the two proteins. Based on these results, we classifi ed 89% of cases (24 out of 27) as HCV-positive HCC and the others as HCV-negative HCC. In addition, the results of immunohistochemical detection of HCV were confi rmed by in situ hybridization detecting HCV RNA. As shown in Fig. 1c , the cytoplasm of HCC cells was stained with T-T dimerized oligo-DNA probe complementary to HCV genome RNA, and the stained HCC cells, indicating the presence of HCV RNA, were distributed in the lobules similarly to HCV protein-positive cells. The adjacent section was hybridized with the 28S rRNA probe as a positive control of RNA preservation (Fig. 1d) , showing that all HCC cells were favorably stained.
Detection of iron deposition
Intracellular deposited iron was detected by Prussian blue staining and was found in 43% of the Myanmar HCC specimens (12 of 28 cases). Iron deposition was detected in 22% (2 out 9) well-differentiated HCCs, and was present in the cytoplasm of some cancer cells and Kupffer cells (Fig. 2b) . However, in welldifferentiated HCC, the staining was only weak and the number of iron-positive cells was very low. On the other hand, in moderately differentiated HCC, iron deposition was detected in 53% of cases (10 of 19), and was found in the cytoplasm of many cancer cells and Kupffer cells (Fig. 2d) . Although the number of poorly differentiated HCC was limited (n = 3), we could not detect iron deposition at all in any of these HCCs. Furthermore, hepatocytes, sinusoidal cells, and endothelial cells in the noncancerous regions of all three types of HCC showed very weak Prussian blue staining. No signifi cant correlations were observed between the iron deposition and the age of the patients (>65 years, 65 years or less), the sex of the patients, the histological classifi cations of HCC, or the presence or absence of HCV and hepatitis B virus (HBV; Table 2 ). The degree of hepatic iron distribution in HCC was assessed according to the HHII based on Prussian blue staining ( Table 3 ). The average HIS (8.0 ± 4.1, mean ± SD) was higher than the average SIS (2.3 ± 1.1) and PIS (1.0 ± 1.3; P < 0.001, respectively; Fig. 3a) . Iron deposition was mainly localized in cancer cells. We also evaluated the intensity of Prussian blue-positive cells, using an image analyzer. The HHII was correlated with the Prussian-blue positive area (r = 0.977; P < 0.0001; Fig. 3b ).
Acceleration of cell proliferation in iron deposit-positive HCC
Cell proliferating activity was assessed by Ki-67 staining. Ki-67-positive cells were abundant in Prussian bluepositive cases (Fig. 4a) , compared with the -negative cases (Fig. 4b) . The Ki-67 LI was signifi cantly higher in iron deposit-positive cases (3.8 ± 2.2) than in -negative cases (1.5 ± 1.7; P = 0.0067). The number of Ki-67-positive cells in moderately differentiated HCC (Fig. 4c) tended to be higher than that in welldifferentiated HCC (Fig. 4d) . However, there was no signifi cant difference in the LI value for Ki-67 positive cells between moderately differentiated and welldifferentiated HCC.
We also evaluated the correlation between cell proliferation (Ki-67 LI) and iron deposition (Prussian bluepositive area [%]). As shown in Fig. 4e , cell proliferation correlated linearly with iron deposition (r = 0.636; P = 0.0263). 
Detection of TUNEL-positive cells and expression of Fas, FasL, and CD8
The TUNEL assay was performed to assess the effect of iron deposition on the frequency of apoptosis of hepatocytes and HCC cells. TUNEL-positive cells were found in cancer cells and lymphocytes (Fig. 5a ). The numbers of TUNEL-positive cells in Prussian bluepositive and -negative cases were not signifi cantly different (data not shown). In the next step, we used immunohistochemistry to clarify the effect of Fas and FasL on the frequency of apoptosis. Fas was expressed in the plasma membrane or cytoplasm of cancer cells (Fig. 5b) . As shown in Fig. 5c , FasL was also detected in the plasma membrane and cytoplasm of cancer cells, as well as in some infi ltrating lymphocytes. In the present study, 74% of HCC cases were positive for Fas and 77% of HCC cases were positive for FasL. Fas and FasL positivity were signifi cantly correlated (Table 4) . Furthermore, Fas and FasL positivity correlated signifi cantly with the TUNEL-LI (Tables 5 and 6 ). Specimens with abundant TUNEL-positive cells contained many CD8-positive cells, which were also FasL-positive (Fig. 5d) . The numbers of CD8+ lymphocytes and TUNEL-posi- Well-diff., well differentiated; mod./poor diff., moderately and poorly differentiated; NS, not signifi cant; HCV core, hepatitis C virus core protein; HCV NS3, hepatitis C virus NS3 protein; HBsAg, hepatitis B surface antigen; LI, labeling index value * P value of less than 0.05 denotes the presence of a statistically signifi cant correlation 
Discussion
In the present study, we fi rst investigated iron deposition by Prussian blue staining and then examined the correlation between such deposition and cell proliferation and apoptosis in Myanmar HCV-positive HCC specimens. In Myanmar, HCV-positive HCC is characterized by juvenile development, compared with the characteristics in Japan and other countries. We found that cell proliferation was signifi cantly higher in Prussian blue-positive HCC cases than in -negative HCC cases, while no correlation was found between iron deposition and the frequency of apoptosis in HCC cells. These results suggest that iron overload may accelerate The strong association of iron overload with HCC progression has been reported recently in studies showing marked improvement of liver function and retardation of progression to HCC in chronically HCV-infected patients who received long-term iron reduction therapy and phlebotomy. 17, 18 In addition, Pigeon et al. 48 have reported a new mouse liver-specifi c gene, HEPC (which encodes a protein homologous to human antimicrobial peptide hepcidin) that is strongly linked with and plays a specifi c role in iron overload. The same study showed reduced hepcidin levels in hepG2 cells when iron was overloaded. Therefore, HCC progression may be infl u- Correlation between Fas expression and FasL expression was examined by χ 2 analysis P value of less than 0.05 denotes the presence of a statistically significant correlation enced by the expression of proteins involved in iron metabolism, such as hepcidin. Interestingly, Furutani et al. 49 reported that, with iron overload, transgenic mice expressing the HCV polyprotein showed hepatic steatosis, ultrastructural mitochondrial alterations, com promised mitochondrial fatty acid degradation, and increased lipid peroxidation products. The number of proliferating hepatocytes was also increased in mice fed the excess-iron diet, and hepatic tumors, including HCC, developed at 12 months in fi ve (45%) of the transgenic mice fed excess iron. This suggests that iron overload induced mitochondrial injury via enhanced oxidative stress and increased the risk of HCC development in transgenic mice expressing the HCV polyprotein. Therefore, it is suggested that HCC progression may be infl uenced by enhanced hepatocyte proliferation triggered directly by iron and/or indirectly via its oxidative effects. A possible mechanism responsible for the iron deposition in our HCC samples from Myanmar patients may have involved abnormal hemoglobins and/or variants. Previously, Win et al. 4 detected iron overload in HCC patients with abnormal hemoglobins and HCV in Myanmar, and also found that the prevalence rate of thalassemia was 25% among the HCC patients, although this rate was not signifi cantly different from that among the Myanmar general population. 50 Interestingly, Rochette et al. 51 detected the H63D (187 C→G) mutation in the hemochromatosis gene (HFE) in Myanmar people; in particular, fi ve mutations (3% of alleles) were detected in 83 unrelated Myanmar people. In patients with the HFE mutation, the hepatic iron deposition is due to increasing luminal ferric reductase activity, divalent metal transporter-1 expression and ferroportin-1 expression, and decreasing enterocyte ferritin stores. 52 Therefore, it is suggested that this mutation may be another possible factor for iron overload in Myanmar.
The Fas and FasL apoptotic system related to cytotoxic lymphocytes in HCV-infected HCC has been recently reported by Fukuzawa et al. 24 They reported the localization of Fas and FasL on the membrane or in the cytoplasm in some HCC cells, as well as in hepatocytes, and noted that the expression of Fas and FasL was enhanced in areas with infi ltrating infl ammatory cells. Moreover, the proportion of TUNEL-positive cells was high around the margin of areas rich in infi ltrating lymphocytes. In the Myanmar HCC samples we examined, we found a similar expression pattern of Fas and FasL, while there were only a few infi ltrating lymphocytes around the cancer nodules. Some lymphocytes that were FasL-positive were also CD8-positive, and the number of TUNEL-positive HCC cells was more abundant in those cases, which included more FasL-positive CD8+ T lymphocytes. In both Japanese and the present Myanmar studies, the expression of Fas/FasL was lower in the cancerous liver tissue than in the surrounding noncancerous regions, and the expression decreased in proportion with the malignancy of tumor cells. However, we could not fi nd TUNEL-positive CD8+ T lymphocytes in Myanmar HCC, unlike the Japanese samples.
In conclusion, our results indicated that iron deposition may, directly or indirectly, accelerate hepatocarcinogenesis by promoting cancer cell proliferation in Myanmar HCC, without affecting the Fas/FasL apoptotic system.
